Literature DB >> 7602615

Kainic acid-induced seizures and brain damage in the rat: role of calcium homeostasis.

M Berg1, T Bruhn, A Frandsen, A Schousboe, N H Diemer.   

Abstract

Seizure activity induced by kainic acid (KA) and subsequent neuronal death are thought to be associated with an increase in cytoplasmic free calcium ([Ca2+]i) and can be prevented by N-methyl-D-aspartate (NMDA) antagonists. In addition to influx through receptor operated Ca2+ channels the increase in [Ca2+]i may be the result of an increased influx through voltage-operated calcium channels and/or release from intracellular deposits. It was therefore investigated whether compounds other than NMDA antagonists with known actions on the intracellular Ca2+ homeostasis had any protective effect against KA-induced neuronal death. Voltage-operated calcium channels in the cell membrane were blocked with the L-type ion channel antagonist, Nimodipine (1.0 mg/kg), and release of Ca2+ from internal stores was prevented with Dantrolene (10 mg/kg). Animals from two control groups injected with kainate (8 mg/kg) exhibited a survival rate of 67 and 53%, respectively. Countings of neurons in dorsal hippocampus showed subtotal or total loss in the CA1 and CA3 subregions. There were no significant differences concerning seizure and survival rates in the groups injected with kainate and treated with Dantrolene or Nimodipine and the control groups. The group treated with Dantrolene showed no neuropathological changes in the hippocampal CA3 region and only slight changes in the Ca1 region, while the neuron loss in the Nimodipine group did not differ from that of its control group. The results emphasize the importance of Dantrolene-sensitive Ca2+ release from intracellular stores for the development of seizure-induced neuronal death.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7602615     DOI: 10.1002/jnr.490400509

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  8 in total

Review 1.  Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders.

Authors:  Mark P Mattson
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

2.  Long-term dantrolene treatment reduced intraneuronal amyloid in aged Alzheimer triple transgenic mice.

Authors:  Zhen Wu; Bin Yang; Chunxia Liu; Ge Liang; Maryellen F Eckenhoff; Weixia Liu; Stephen Pickup; Qingcheng Meng; Yuke Tian; Shitong Li; Huafeng Wei
Journal:  Alzheimer Dis Assoc Disord       Date:  2015 Jul-Sep       Impact factor: 2.703

3.  Carisbamate blockade of T-type voltage-gated calcium channels.

Authors:  Do Young Kim; Fang-Xiong Zhang; Stan T Nakanishi; Timothy Mettler; Ik-Hyun Cho; Younghee Ahn; Florian Hiess; Lina Chen; Patrick G Sullivan; S R Wayne Chen; Gerald W Zamponi; Jong M Rho
Journal:  Epilepsia       Date:  2017-02-23       Impact factor: 5.864

4.  Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2.

Authors:  Jing Liu; Tie-Shan Tang; Huiping Tu; Omar Nelson; Emily Herndon; Duong P Huynh; Stefan M Pulst; Ilya Bezprozvanny
Journal:  J Neurosci       Date:  2009-07-22       Impact factor: 6.167

5.  Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 3.

Authors:  Xi Chen; Tie-Shan Tang; Huiping Tu; Omar Nelson; Mark Pook; Robert Hammer; Nobuyuki Nukina; Ilya Bezprozvanny
Journal:  J Neurosci       Date:  2008-11-26       Impact factor: 6.167

6.  Dynamic regulation of ryanodine receptor type 1 (RyR1) channel activity by Homer 1.

Authors:  Wei Feng; Jiancheng Tu; Pierre Pouliquin; Elaine Cabrales; Xiaohua Shen; Angela Dulhunty; Paul F Worley; Paul D Allen; Isaac N Pessah
Journal:  Cell Calcium       Date:  2007-08-17       Impact factor: 6.817

Review 7.  Dantrolene: mechanisms of neuroprotection and possible clinical applications in the neurointensive care unit.

Authors:  Susanne Muehlschlegel; John R Sims
Journal:  Neurocrit Care       Date:  2008-08-12       Impact factor: 3.532

8.  Dantrolene is neuroprotective in Huntington's disease transgenic mouse model.

Authors:  Xi Chen; Jun Wu; Svetlana Lvovskaya; Emily Herndon; Charlene Supnet; Ilya Bezprozvanny
Journal:  Mol Neurodegener       Date:  2011-11-25       Impact factor: 14.195

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.